SBIR/STTR Research Award

Biocompatible Antimicrobial Treatment Method for the Prevention of Bovine Mastitis

Award identifier 1f26b0e076cbaee995cd73330592cb8dc29cf78207a77fc864888776ce5ee998Awarding agency Department of Agriculture

Award amount

$181,429

Program and phase

SBIR · Phase I

Award year

2025

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Agriculture
Branch
Not reported
Recipient company
GINER INC
Proposal award date
2025-09-10
Contract end date
2026-05-14
UEI
ULB2NMDNXC69
Solicitation number
USDA-NIFA-SBIR-010774
Topic code
8.3

Research abstract

A major challenge facing America's dairy farms is the frequent occurrence of bacterial infections in dairy cattle. Even when good sanitary practices are maintained, upwards of 30% of dairy cattle are dealing with infections during the milking period. Mammary gland infections in cows, a condition known as bovine mastitis, causes abnormal milk production and is typically treated with antibiotics. Continued antibiotic use has led to antibiotic-resistant bacteria strains, and milk from dairy cattle undergoing antibiotic treatments must be discarded. Antibiotic-resistant strains lead to longer lasting infections and discarding milk results in a significant cost to the farmer. This challenge presents an opportunity for the development of new methods that reduce the risk of mastitis, avoid the use of antibiotics, and secure American dairy farms.Giner's approach to solve this issue utilizes bacteriophages. Bacteriophages are the natural predators of bacteria which are effective at destroying harmful bacteria, pose no safety concerns to dairy cattle or humans, and can be grown in high volumes at low cost. These naturally-occurring bacteriophages will be part of a proprietary blend of safe ingredients that will be applied directly to animal skin (teats, udders and compromised skin areas) to eliminate harmful bacteria on contact and provide prolonged protection while leaving the animal unharmed. Giner's bacteriophage blend will be optimized to adhere well to animal skin, survive a wide temperature range and demonstrate effectiveness towards harmful bacteria. After several development rounds of optimization, Giner's product will be applied directly to dairy cattle as part of a live-animal study performed at the University of New Hampshire. The goal of the study is to demonstrate a reduction in harmful bacteria relative to untreated cows with no negative impacts to the animal skin. If this goal is met, the product is intended to be a drop-in replacement to current sanitation methods and can be adopted by dairy farms across America. This will increase the milk yield of dairy farms, reduce reliance on antibiotics, and decrease losses farmers face from mastitis.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

447 SBIR/STTR records share this UEI (1983–2025). Reported award amounts total $147,003,828. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, Department of Health and Human Services, Department of Energy, National Aeronautics and Space Administration, National Science Foundation, Department of Agriculture

Agency intelligence

Department of Agriculture

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.